Oncology Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others), By Nutrition (Enteral Nutrition, Parenteral Nutrition), By Formula (Standard Formula, Elemental Formula, Specialized Formula), By Formula (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics), By Region, By Competition Forecast & Opportunities, 2018-2028F

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4900

Multi-User Licence

$5900

Custom Research Licence

$8900

Summary

Request Sample

Report Description

Forecast Period	2024-2028
Market Size (2022)	USD 2.14 billion
CAGR (2023-2028)	8.41%
Fastest Growing Segment	Enteral Nutrition
Largest Market	North America

Market Overview

Global Oncology Nutrition Market has valued at USD 2.14 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.41% through 2028. The global oncology nutrition market refers to the healthcare segment focused on providing specialized nutritional products and services to cancer patients. Cancer and its treatment can significantly impact a patient's nutritional needs and overall health. Oncology nutrition aims to address these challenges by providing tailored solutions to support patients during their cancer journey.

Key Market Drivers

Rising Cancer Incidence

The global oncology nutrition market is witnessing a significant surge in demand, and one of the key drivers behind this growth is the alarming increase in cancer incidence worldwide. As cancer continues to affect more lives each year, the need for specialized nutritional support has never been greater. Cancer has reached epidemic proportions, with its incidence steadily rising across the globe. According to the World Cancer Research Fund, new cancer cases are projected to increase by approximately 60% by 2040. This surge in cancer diagnoses is creating a substantial pool of potential patients who require oncology nutrition products and services. Cancer is not a singular disease but rather a group of diseases with various types and stages. Each type of cancer and individual patient may have unique nutritional needs. This diversity within the cancer patient population has driven the development of a wide range of oncology nutrition solutions tailored to specific requirements. Cancer and its treatments, including chemotherapy, radiation therapy, and surgery, can lead to a host of nutritional challenges. These challenges include weight loss, muscle wasting, malnutrition, loss of appetite, and difficulty swallowing. Oncology nutrition plays a crucial role in addressing these issues, enhancing patients' quality of life and overall health. Adequate nutrition is vital for patients undergoing cancer treatment. Nutritional support can help patients better tolerate treatments, maintain their strength, and recover more swiftly from the side effects of therapy. This, in turn, can improve treatment efficacy and reduce complications, ultimately benefiting both patients and healthcare systems. The rising cancer incidence has also led to increased emphasis on cancer prevention and survivorship. Nutrition plays a pivotal role in both aspects of cancer care. Nutritional interventions are being used to reduce the risk of cancer development and improve the long-term health of cancer survivors, further expanding the market for oncology nutrition products and services. With the increasing recognition that each cancer patient's nutritional needs are unique, there has been a growing trend toward personalized nutrition plans. Healthcare providers are tailoring dietary recommendations to individual patients, taking into account their specific cancer type, treatment regimen, and overall health status. Cancer knows no boundaries, affecting people worldwide. As the importance of proper nutrition in cancer care becomes more widely acknowledged, the global oncology nutrition market is expanding its reach. It is not confined to developed countries but also serves patients in developing nations, creating a more extensive market footprint.

Nutritional Challenges in Cancer Patients

The global oncology nutrition market has been experiencing significant growth, and one of the pivotal factors propelling this expansion is the recognition of nutritional challenges faced by cancer patients. The journey of a cancer patient is fraught with various difficulties, and maintaining proper nutrition is a critical aspect of their care. Cancer and its treatments often lead to weight loss and malnutrition in patients. The metabolic changes caused by the disease can result in muscle waste and a decrease in body weight. Malnutrition can compromise the patient's overall health and weaken their ability to tolerate treatment. Many cancer patients experience a loss of appetite, a condition known as anorexia-cachexia syndrome. This loss of interest in food can result from both the cancer itself and the side effects of treatment. Oncology nutrition products and interventions are designed to address this challenge by providing nutrient-dense solutions that are easier for patients to consume. Certain cancers, particularly those affecting the throat or esophagus, can cause difficulty in swallowing, known as dysphagia. This condition makes it challenging for patients to eat regular meals. Oncology nutrition includes solutions like liquid diets and tube feeding, which circumvent the need for traditional solid food intake. Proper nutrition plays a pivotal role in improving the quality of life for cancer patients. Malnutrition and associated symptoms can lead to fatigue, weakness, and a diminished sense of well-being. Oncological nutrition products are formulated to combat these issues, helping patients feel better during their treatment journey. Nutritional support is vital to help patients better tolerate the rigors of cancer treatment, including chemotherapy, radiation therapy, and surgery. Adequate nutrition can enhance treatment efficacy by ensuring that the patient's body is strong enough to withstand the demands of therapy. This, in turn, can lead to better treatment outcomes. The recognition that cancer patients have unique nutritional needs has driven the development of personalized nutrition plans. Healthcare providers tailor dietary recommendations to each patient, taking into account factors such as cancer type, treatment regimen, and overall health status. This individualized approach is a significant driver of growth in the oncology nutrition market. The field of oncology nutrition is characterized by continuous innovation. Companies are investing in research and development to create new and improved nutritional products and services that cater to the evolving needs of cancer patients. These innovations include specialized oral supplements, enteral and parenteral nutrition solutions, and dietary guidelines specifically for cancer patients.

Advancements in Medical Research

The global oncology nutrition market is experiencing remarkable growth, with advancements in medical research playing a pivotal role in its expansion. As our understanding of cancer and its treatment continues to evolve, so too does our recognition of the critical role that nutrition plays in the well-being and recovery of cancer patients. Medical research has deepened our understanding of the complexities of cancer. We now know that cancer is not a single disease but a group of diseases with distinct characteristics. This nuanced understanding has led to the development of tailored nutritional interventions designed to address the unique needs of different cancer types and stages. Research has shed light on the profound impact of nutrition on cancer patients' outcomes. It has become increasingly clear that maintaining proper nutrition is essential for both managing the side effects of cancer treatment and improving patients' overall quality of life. Advancements in medical research have revealed how nutrition can mitigate the adverse side effects of cancer treatments such as chemotherapy and radiation therapy. Proper nutrition can help patients better tolerate treatment, reducing the severity of symptoms such as nausea, vomiting, and fatigue. Research has shown that nutrition plays a pivotal role in supporting the immune system, which is crucial in the fight against cancer. Nutritional interventions can boost immune function, potentially enhancing the body's ability to combat cancer cells and reduce the risk of complications during treatment. Medical research has emphasized the importance of personalized medicine, and this approach has extended to oncology nutrition. Research findings have led to the development of individualized nutrition plans that consider factors such as the patient's specific cancer type, treatment regimen, and overall health status. These personalized plans are more effective in addressing the unique nutritional challenges of each patient. Advancements in research have driven innovation in the development of oncology nutrition products. Companies in the market are investing in research and development to create improved oral nutritional supplements, enteral and parenteral nutrition solutions, and dietary guidelines tailored to cancer patients' needs.

Market Innovation

The global oncology nutrition market is experiencing robust growth, and one of the key engines propelling this expansion is market innovation. In the quest to provide effective solutions for cancer patients' unique nutritional needs, companies are pushing the boundaries of research and development, creating novel products and services. Market innovation has led to a diverse portfolio of oncology nutrition products and services. Companies are continually developing new and improved solutions that cater to the evolving needs of cancer patients. This includes a wide range of oral nutritional supplements, enteral and parenteral nutrition options, and dietary guidelines tailored specifically for cancer patients. Innovations in formulation techniques have resulted in more effective oncology nutrition products. These products are designed to provide essential nutrients in an easily digestible form. Enhanced formulations ensure that patients receive the necessary nutrients, even if they have difficulty eating solid foods due to cancer and its treatments. Market innovation has driven the adoption of personalized nutrition plans in oncology. Healthcare providers are recognizing that each cancer patient's nutritional needs are unique, and customized dietary recommendations are becoming the norm. These tailored plans consider factors such as the patient's cancer type, treatment regimen, and overall health status. Technology is playing a significant role in market innovation. Mobile apps and digital platforms are being used to facilitate communication between patients and healthcare providers. These tools help patients track their dietary intake, receive personalized nutrition guidance, and monitor their progress, improving adherence to nutrition plans. Innovation in the oncology nutrition market has fostered a patient-centered approach. Companies are focusing on patient education and engagement, ensuring that patients are well-informed about the importance of nutrition in their cancer journey. Patient-centered approaches enhance treatment compliance and overall well-being. Companies are investing heavily in research and development to drive innovation. This investment fuels the creation of cutting-edge nutritional products and services. Research efforts are directed toward understanding the nutritional needs of cancer patients and developing solutions that address these needs comprehensively.

Download Free Sample Report

Key Market Challenges

Regulatory Hurdles

One of the primary challenges in the oncology nutrition market is navigating the complex web of regulatory requirements. Different countries have varying regulations regarding the production and distribution of nutritional products and dietary supplements. Meeting these standards can be demanding and time-consuming for companies operating on a global scale.

Treatment-Related Side Effects

Cancer treatments like chemotherapy and radiation therapy often lead to debilitating side effects, including nausea, vomiting, and loss of appetite. Developing nutrition solutions that can effectively address these side effects and maintain the patient's nutritional status is a continuous challenge.

Patient Compliance

Ensuring patient compliance with recommended nutrition plans can be challenging. Cancer patients may struggle with adherence due to factors like taste changes, lack of appetite, or difficulty in swallowing. Educating and motivating patients to follow their prescribed nutrition plans is a critical challenge for healthcare providers.

Cost Constraints

Cancer patients often face significant financial burdens related to their treatment, and the cost of specialized oncology nutrition products can be prohibitive. Balancing the need for effective nutrition support with cost constraints is a challenging aspect of market growth.

Key Market Trends

Nutrigenomics

Nutrigenomics is an emerging field that explores the interaction between an individual's genetics and their dietary choices. In the oncology nutrition market, this means using genetic information to create nutrition plans that are specifically designed to target the unique needs and vulnerabilities of each patient. This trend has the potential to revolutionize how we approach nutrition in cancer care.

Digital Health Solutions

The integration of digital health solutions is set to revolutionize oncology nutrition. Mobile apps, wearable devices, and telehealth platforms will play a more prominent role in monitoring and managing patients' nutritional needs. These tools will enable real-time tracking of dietary intake, symptom management, and remote consultations with healthcare providers.

Functional Foods and Nutraceuticals

There is growing interest in the development of functional foods and nutraceuticals tailored to the needs of cancer patients. These products go beyond traditional supplements, offering targeted nutritional support with added bioactive compounds that may help manage cancer-related symptoms and side effects.

Sustainable and Ethical Nutrition

Sustainability and ethical considerations are becoming more prominent in the oncology nutrition market. Patients and healthcare providers are showing interest in nutrition products that are not only effective but also produced in an environmentally responsible and ethically sourced manner.

Segmental Insights

Cancer Type Insights

Based on the category of Cancer Type, the lung cancer segment is expected to experience growth throughout the study period due to several factors. These include the global high prevalence of lung cancer, an increase in the use of nutritional supplements for lung cancer patients, and a growing awareness of the importance of incorporating nutritional supplements into one's diet. For example, according to the Lung Cancer Fact 2022 report, lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States alone, it was estimated that 236,740 individuals would be diagnosed with lung cancer in 2022, with 1 in 16 people receiving a lung cancer diagnosis during their lifetime (1 in 15 men and 1 in 17 women). With the rising number of cancer patients, there is a growing recognition of the vital role nutrition plays in bolstering the body's ability to combat disease and in providing the necessary strength and stamina to endure the side effects of treatment. As a result, the demand for oncology nutrition is expected to increase over the forecasted period.

Additionally, government initiatives are actively promoting proper nutrition for individuals undergoing cancer treatment and beyond. To support this objective, regulatory agencies are streamlining and revising regulations related to nutrition. As an example, in May 2021, U.S. Senators Susan Collins (R-ME) and Gary Peters (D-MI) introduced bipartisan legislation known as the "Medical Nutrition Therapy Act." This legislation aims to expand Medicare Part B coverage to include medical nutrition therapy (MNT) services for a broader range of conditions, including cancer, prediabetes, eating disorders, malnutrition, gastrointestinal diseases (such as celiac disease), cardiovascular disease, HIV/AIDS, and other conditions that result in unintentional weight loss. Such policy initiatives are likely to provide financial support to individuals and motivate them to be more proactive in incorporating nutritional supplements into their routines, thereby fostering growth in the market.

End User Insights

Hospital Pharmacy is poised to dominate the Global Oncology Nutrition Market for several compelling reasons. Firstly, hospitals serve as primary hubs for cancer diagnosis and treatment, making them central to the oncology care continuum. As a result, they play a pivotal role in prescribing and administering specialized oncology nutrition solutions tailored to individual patient needs. Secondly, hospital pharmacies have the infrastructure and expertise to manage complex pharmaceutical and nutritional requirements for cancer patients, ensuring precise dosing, safety, and compliance. Thirdly, the increasing incidence of cancer cases worldwide demands a consolidated and regulated approach to oncology nutrition, which hospital pharmacies are uniquely equipped to provide. Moreover, hospital pharmacies often collaborate with multidisciplinary teams of oncologists, dietitians, and healthcare professionals, ensuring a comprehensive and patient-centric approach to nutrition therapy. These factors, coupled with the growing recognition of the critical role of nutrition in cancer care, position hospital pharmacies as the dominant players in the evolving Global Oncology Nutrition Market.

Download Free Sample Report

Regional Insights

North America is anticipated to experience growth in the overall oncology nutrition market throughout the projected period. This can be attributed to various factors, including the increasing prevalence of cancer and the presence of advanced healthcare infrastructure, among other significant drivers. For instance, the American Cancer Society's 2022 report estimates approximately 1.9 million new cancer cases in the United States for the same year. Additionally, initiatives by government bodies, new product launches, and collaborations related to cancer nutrition supplements are contributing to market expansion. For example, the "2022 Oncology Nutrition Symposium" conducted by the Academy of Nutrition and Dietetics on June 20, 2022, addressed various aspects of oncology nutrition, encompassing research, prevention, treatment, recovery, palliative care, and hospice.

Furthermore, the Canadian Cancer Society forecasts 233,900 new cancer cases in Canada in 2022. The rising incidence of cancer cases across North America is expected to fuel market growth. Moreover, the region conducts numerous certification programs and awareness initiatives aimed at educating cancer patients and healthcare providers about the significance of oncology nutrition. One such example is the Oncology Nutrition Institute (ONI), which offers evidence-based educational certification and training programs in modern, metabolic, innovative, integrative, and outcomes-based oncology nutrition therapy. Their flagship 250-hour Oncology Nutrition Consulting (ONC) certification program is a comprehensive training course designed for qualified nutrition, health, and medical practitioners. Consequently, the increasing number of cancer cases is projected to drive demand for oncology nutrition, ultimately stimulating market growth.

Recent Developments

In July 2022, Nestle introduced China's inaugural Foods for Special Medical Purpose (FSMP) designed for patients dealing with tumor-related conditions. This achievement came after a rigorous five-year approval process with Chinese regulatory authorities.
In January 2022, Faeth Therapeutics successfully concluded a Series A funding round, securing USD 47 million in private financing, with S2G Ventures as the lead investor. This funding round brought their total capital raised to USD 67 million thus far. The proceeds from this financing will be allocated towards advancing Faeth's clinical trials, which employ a combination of nutrient management, pharmaceuticals, and digital tools to inhibit the growth of cancer.

Key Market Players

Abbott Laboratories Inc
Nestle SA
Fresenius Kabi AG
B Braun SE
Hormel Foods Corporation
Danone SA
MEIJI Holdings Co Ltd
Global Health Products, Inc.
Victus Inc
Mead Johnson & Co LLC

By Cancer Type	By Nutrition	By Formula	By Distribution Channel	By End User	By Region
Lung Cancer Head and Neck Cancer Stomach and Gastrointestinal Cancers Esophageal Cancer Liver Cancer Blood Cancer Others	Enteral Nutrition Parenteral Nutrition	Standard Formula Elemental Formula Specialized Formula	Hospital Pharmacy Online Pharmacy Retail Pharmacy	Hospitals Homecare Specialty Clinics	North America Europe Asia-Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Oncology Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Nutrition Market, By Cancer Type:

o Lung Cancer

o Head and Neck Cancer

o Stomach and Gastrointestinal Cancers

o Esophageal Cancer

o Liver Cancer

o Blood Cancer

o Others

Oncology Nutrition Market, By Nutrition:

o Enteral Nutrition

o Parenteral Nutrition

Oncology Nutrition Market, By Formula:

o Standard Formula

o Elemental Formula

o Specialized Formula

Oncology Nutrition Market, By Distribution Channel:

o Hospital Pharmacy

o Online Pharmacy

o Retail Pharmacy

Oncology Nutrition Market, By End User:

o Hospitals

o Homecare

o Specialty Clinics

Oncology Nutrition Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ Germany

§ United Kingdom

§ France

§ Italy

§ Spain

o Asia-Pacific

§ China

§ Japan

§ India

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oncology Nutrition Market.

Available Customizations:

Global Oncology Nutrition market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Oncology Nutrition Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oncology Nutrition Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)

5.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)

5.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)

5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

5.2.5. By End User (Hospitals, Homecare, Specialty Clinics)

5.2.6. By Region

5.2.7. By Company (2022)

5.3. Product Market Map

5.3.1. By Cancer Type

5.3.2. By Nutrition

5.3.3. By Formula

5.3.4. By Distribution Channel

5.3.5. By End User

5.3.6. By Region

6. North America Oncology Nutrition Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)

6.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)

6.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)

6.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

6.2.5. By End User (Hospitals, Homecare, Specialty Clinics)

6.2.6. By Country

6.3. North America: Country Analysis

6.3.1. United States Oncology Nutrition Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Cancer Type

6.3.1.2.2. By Nutrition

6.3.1.2.3. By Formula

6.3.1.2.4. By Distribution Channel

6.3.1.2.5. By End User

6.3.2. Canada Oncology Nutrition Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Cancer Type

6.3.2.2.2. By Nutrition

6.3.2.2.3. By Formula

6.3.2.2.4. By Distribution Channel

6.3.2.2.5. By End User

6.3.3. Mexico Oncology Nutrition Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Cancer Type

6.3.3.2.2. By Nutrition

6.3.3.2.3. By Formula

6.3.3.2.4. By Distribution Channel

6.3.3.2.5. By End User

7. Europe Oncology Nutrition Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)

7.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)

7.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)

7.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

7.2.5. By End User (Hospitals, Homecare, Specialty Clinics)

7.2.6. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Oncology Nutrition Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Cancer Type

7.3.1.2.2. By Nutrition

7.3.1.2.3. By Formula

7.3.1.2.4. By Distribution Channel

7.3.1.2.5. By End User

7.3.2. United Kingdom Oncology Nutrition Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Cancer Type

7.3.2.2.2. By Nutrition

7.3.2.2.3. By Formula

7.3.2.2.4. By Distribution Channel

7.3.2.2.5. By End User

7.3.3. France Oncology Nutrition Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Cancer Type

7.3.3.2.2. By Nutrition

7.3.3.2.3. By Formula

7.3.3.2.4. By Distribution Channel

7.3.3.2.5. By End User

7.3.4. Italy Oncology Nutrition Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Cancer Type

7.3.4.2.2. By Nutrition

7.3.4.2.3. By Formula

7.3.4.2.4. By Distribution Channel

7.3.4.2.5. By End User

7.3.5. Spain Oncology Nutrition Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Cancer Type

7.3.5.2.2. By Nutrition

7.3.5.2.3. By Formula

7.3.5.2.4. By Distribution Channel

7.3.5.2.5. By End User

8. Asia-Pacific Oncology Nutrition Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)

8.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)

8.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)

8.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

8.2.5. By End User (Hospitals, Homecare, Specialty Clinics)

8.2.6. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Oncology Nutrition Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Cancer Type

8.3.1.2.2. By Nutrition

8.3.1.2.3. By Formula

8.3.1.2.4. By Distribution Channel

8.3.1.2.5. By End User

8.3.2. Japan Oncology Nutrition Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Cancer Type

8.3.2.2.2. By Nutrition

8.3.2.2.3. By Formula

8.3.2.2.4. By Distribution Channel

8.3.2.2.5. By End User

8.3.3. India Oncology Nutrition Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Cancer Type

8.3.3.2.2. By Nutrition

8.3.3.2.3. By Formula

8.3.3.2.4. By Distribution Channel

8.3.3.2.5. By End User

8.3.4. Australia Oncology Nutrition Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Cancer Type

8.3.4.2.2. By Nutrition

8.3.4.2.3. By Formula

8.3.4.2.4. By Distribution Channel

8.3.4.2.5. By End User

8.3.5. South Korea Oncology Nutrition Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Cancer Type

8.3.5.2.2. By Nutrition

8.3.5.2.3. By Formula

8.3.5.2.4. By Distribution Channel

8.3.5.2.5. By End User

9. South America Oncology Nutrition Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)

9.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)

9.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)

9.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

9.2.5. By End User (Hospitals, Homecare, Specialty Clinics)

9.2.6. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Oncology Nutrition Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Cancer Type

9.3.1.2.2. By Nutrition

9.3.1.2.3. By Formula

9.3.1.2.4. By Distribution Channel

9.3.1.2.5. By End User

9.3.2. Argentina Oncology Nutrition Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Cancer Type

9.3.2.2.2. By Nutrition

9.3.2.2.3. By Formula

9.3.2.2.4. By Distribution Channel

9.3.2.2.5. By End User

9.3.3. Colombia Oncology Nutrition Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Cancer Type

9.3.3.2.2. By Nutrition

9.3.3.2.3. By Formula

9.3.3.2.4. By Distribution Channel

9.3.3.2.5. By End User

10. Middle East and Africa Oncology Nutrition Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)

10.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)

10.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)

10.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

10.2.5. By End User (Hospitals, Homecare, Specialty Clinics)

10.2.6. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Oncology Nutrition Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Cancer Type

10.3.1.2.2. By Nutrition

10.3.1.2.3. By Formula

10.3.1.2.4. By Distribution Channel

10.3.1.2.5. By End User

10.3.2. Saudi Arabia Oncology Nutrition Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Cancer Type

10.3.2.2.2. By Nutrition

10.3.2.2.3. By Formula

10.3.2.2.4. By Distribution Channel

10.3.2.2.5. By End User

10.3.3. UAE Oncology Nutrition Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Cancer Type

10.3.3.2.2. By Nutrition

10.3.3.2.3. By Formula

10.3.3.2.4. By Distribution Channel

10.3.3.2.5. By End User

10.3.4. Kuwait Oncology Nutrition Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Cancer Type

10.3.4.2.2. By Nutrition

10.3.4.2.3. By Formula

10.3.4.2.4. By Distribution Channel

10.3.4.2.5. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Porter’s Five Forces Analysis

13.1. Competition in the Industry

13.2. Potential of New Entrants

13.3. Power of Suppliers

13.4. Power of Customers

13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Business Overview

14.2. Product Offerings

14.3. Recent Developments

14.4. Financials (As Reported)

14.5. Key Personnel

14.6. SWOT Analysis

14.6.1. Abbott Laboratories Inc

14.6.2. Nestle SA

14.6.3. Fresenius Kabi AG

14.6.4. B Braun SE

14.6.5. Hormel Foods Corporation

14.6.6. Danone SA

14.6.7. MEIJI Holdings Co Ltd

14.6.8. Global Health Products, Inc.

14.6.9. Victus Inc

14.6.10. Mead Johnson & Co LLC

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

What was the market size of the Global Oncology Nutrition Market in 2022?

The market size of the Global Oncology Nutrition Market was estimated to be USD 2.14 billion in 2022.

Who are the top players operating in the Global Oncology Nutrition Market in 2022?

Abbott Laboratories Inc, Nestle SA, Fresenius Kabi AG, B Braun SE, Hormel Foods Corporation, Danone SA, MEIJI Holdings Co Ltd, Global Health Products, Inc., Victus Inc, Mead Johnson & Co LLC are some of the key players operating in the Global Oncology Nutrition Market.

What are the challenges faced by the Global Oncology Nutrition Market in the upcoming years?

Treatment-related side effects, patient compliance, limited awareness, are some of the major challenges faced by the Global Oncology Nutrition Market in the upcoming years.

What are the major drivers for the Global Oncology Nutrition Market?

Nutritional challenges in cancer patients and advancements in medical research are the major drivers for the Global Oncology Nutrition Market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Oncology Nutrition Market to Grow with a CAGR of 8.41% through 2028

Sep, 2023

Increasing incidence of cancer and the recognition of nutritional challenges in cancer patients are expected to drive the Global Oncology Nutrition Market growth in the forecast period, 2024-2028.